Patho-biological aspects of basal-like breast cancer

Breast Cancer Research and Treatment

Volumn 113, Issue 3, 2009, Pages 411-422

  Rakha, Emad A ^a   El Sayed, Maysa E ^a   Reis Filho, Jorge ^b   Ellis, Ian O ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Basal like; Breast cancer; Definition; Morphology; Prognosis

Indexed keywords

BREAST CANCER; CANCER STEM CELL; CLINICAL FEATURE; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENES, BRCA1; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASTIC STEM CELLS; PROGNOSIS;

EID: 58549119990     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9952-1     Document Type: Review

References (135)

1. MW Beckmann 1997 Multistep carcinogenesis of breast cancer and tumour heterogeneity J Mol Med 75 6 429 439
2. CM Perou 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752
3. T Sorlie 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 10869 10874
4. T Sorlie 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 14 8418 8423
5. F Bertucci 2000 Gene expression profiling of primary breast carcinomas using arrays of candidate genes Hum Mol Genet 9 20 2981 2991
6. A Bergamaschi 2006 Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer Genes Chromosomes Cancer 45 11 1033 1040
7. K Chin 2006 Genomic and transcriptional aberrations linked to breast cancer pathophysiologies Cancer Cell 10 6 529 541
8. RM Neve 2006 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 6 515 527
9. H Zhao 2004 Different gene expression patterns in invasive lobular and ductal carcinomas of the breast Mol Biol Cell 15 6 2523 2536
10. C Sotiriou 2006 Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 4 262 272
11. C Sotiriou 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 18 10393 10398
12. SH Dairkee 1987 Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease Breast Cancer Res Treat 10 1 11 20
13. D Santini 1996 Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression J Pathol 179 4 386 391
14. K Savage 2007 Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis Clin Cancer Res 13 1 90 101
15. F Yehiely 2006 Deconstructing the molecular portrait of basal-like breast cancer Trends Mol Med 12 11 537 544
16. Z Hu 2006 The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 7 96
17. K Wilhelmsen SH Litjens A Sonnenberg 2006 Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis Mol Cell Biol 26 8 2877 2886
18. B Vogelstein KW Kinzler 2004 Cancer genes and the pathways they control Nat Med 10 8 789 799
19. N Koshikawa 2000 Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 J Cell Biol 148 3 615 624
20. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70
21. N Dumont CL Arteaga 2003 Targeting the TGF beta signaling network in human neoplasia Cancer Cell 3 6 531 536
22. JD Molkentin 2000 The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression J Biol Chem 275 50 38949 38952
23. C Fan 2006 Concordance among gene-expression-based predictors for breast cancer N Engl J Med 355 6 560 569
24. S Paik 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 27 2817 2826
25. MJ van de Vijver 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 25 1999 2009
26. HY Chang 2005 Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proc Natl Acad Sci USA 102 10 3738 3743
27. XJ Ma 2004 A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen Cancer Cell 5 6 607 616
28. H Dai 2005 A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients Cancer Res 65 10 4059 4066
29. AV Ivshina 2006 Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer Cancer Res 66 21 10292 10301
30. J Stingl 2006 Purification and unique properties of mammary epithelial stem cells Nature 439 7079 993 997
31. TO Nielsen 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 16 5367 5374
32. LN Harris 2007 Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer Clin Cancer Res 13 4 1198 1207
33. M Jumppanen 2007 Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers Breast Cancer Res 9 1 R16
34. M Laakso 2006 Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer Clin Cancer Res 12 14 Pt 1 4185 4191
35. SM Rodriguez-Pinilla 2007 Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas J Clin Pathol 60 9 1006 1012
36. LA Carey 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study Jama 295 21 2492 2502
37. CA Livasy 2007 Identification of a basal-like subtype of breast ductal carcinoma in situ Hum Pathol 38 2 197 204
38. SM Rodriguez-Pinilla 2007 Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer Mod Pathol 20 4 474 481
39. SM Rodriguez-Pinilla 2007 Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study Am J Surg Pathol 31 4 501 508
40. SM Pinilla 2006 Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer Breast Cancer Res Treat 99 1 85 90
41. I Matos 2005 p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas Virchows Arch 447 4 688 694
42. J Paredes 2007 P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ Virchows Arch 450 1 73 80
43. LA Carey 2007 The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 8 2329 2334
44. CA Livasy 2006 Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 2 264 271
45. MJ Kim 2006 Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes Hum Pathol 37 9 1217 1226
46. M Laakso 2005 Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors Mod Pathol 18 10 1321 1328
47. H Li 2007 Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors Cancer Res 67 2 501 510
48. SR Lakhani 2005 Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 11 14 5175 5180
49. WD Foulkes 2004 The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer Cancer Res 64 3 830 835
50. S Banerjee 2006 Basal-like breast carcinomas: clinical outcome and response to chemotherapy J Clin Pathol 59 729 735
51. LG Fulford 2007 Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival Breast Cancer Res 9 1 R4
52. C Jones 2004 Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes Clin Cancer Res 10 18 5988 5997
53. P Potemski 2005 Prognostic relevance of basal cytokeratin expression in operable breast cancer Oncology 69 6 478 485
54. K Malzahn 1998 Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas Virchows Arch 433 2 119 129
55. BA Gusterson 2005 Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer Breast Cancer Res 7 143 148
56. SH Dairkee 1987 Monoclonal marker that predicts early recurrence of breast cancer Lancet 1 514
57. M Tischkowitz 2007 Use of immunohistochemical markers can refine prognosis in triple negative breast cancer BMC Cancer 7 1 134
58. Tan DS et al (2007) Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat [Epub ahead of print]
59. EA Rakha 2006 Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation J Pathol 208 4 495 506
60. R Kusinska 2005 Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma-relation with grade, stage, estrogen receptor and HER2 Pol J Pathol 56 3 107 110
61. EA Rakha 2006 Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance Eur J Cancer 42 18 3149 3156
62. A Ribeiro-Silva 2005 p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer Histopathology 47 5 458 466
63. LG Fulford 2006 Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast Histopathology 49 1 22 34
64. C Jones 2001 CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation Br J Cancer 85 3 422 427
65. JS Reis-Filho 2006 Metaplastic breast carcinomas are basal-like tumours Histopathology 49 1 10 21
66. A Bankfalvi 2004 Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases Mod Pathol 17 9 1051 1061
67. M van de Rijn 2002 Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 6 1991 1996
68. P Tang 2006 Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers Ann Clin Lab Sci 36 1 16 22
69. BB Bryan SJ Schnitt LC Collins 2006 Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer Mod Pathol 19 617 621
70. T Tot 2000 The cytokeratin profile of medullary carcinoma of the breast Histopathology 37 2 175 181
71. J Stingl C Caldas 2007 Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis Nat Rev Cancer 7 791 799
72. R Moll 1998 Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors Subcell Biochem 31 205 262
73. W Bocker 2002 Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept Lab Invest 82 6 737 746
74. E Charafe-Jauffret 2007 Moesin expression is a marker of basal breast carcinomas Int J Cancer 121 8 1779 1785
75. SM Rodriguez-Pinilla 2006 Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas Clin Cancer Res 12 5 1533 1539
76. SM Pinilla 2006 Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer Breast Cancer Res Treat 99 85 90
77. JS Reis-Filho 2003 Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast Appl Immunohistochem Mol Morphol 11 1 1 8
78. S Leibl 2005 Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers Am J Surg Pathol 29 3 347 353
79. R Dent 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 15 4429 4434
80. B Kreike 2007 Gene expression profiling and histopathological characterization of triple negative/basal-like breast carcinomas Breast Cancer Res 9 5 R65
81. EA Rakha 2007 Prognostic markers in triple-negative breast cancer Cancer 109 1 25 32
82. FC Bidard 2007 Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers Ann Oncol 18 7 1285 1286
83. EA Rakha 2007 Are triple negative tumours and basal-like breast cancer synonymous? Breast Cancer Res 9 6 R80
84. R Rouzier 2005 Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 16 5678 5685
85. Tan DS et al (2007) Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat [Epub ahead of print]
86. A Rody 2007 The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial Breast 16 3 235 240
87. DM Abd El-Rehim 2004 Expression of luminal and basal cytokeratins in human breast carcinoma J Pathol 203 2 661 671
88. A Rhodes 2000 Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems J Clin Pathol 53 2 125 130
89. AC Wolff 2007 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 1 118 145
90. M West 2001 Predicting the clinical status of human breast cancer by using gene expression profiles Proc Natl Acad Sci USA 98 20 11462 11467
91. XR Yang 2007 Differences in risk factors for breast cancer molecular subtypes in a population-based study Cancer Epidemiol Biomarkers Prev 16 3 439 443
92. S Calza 2006 Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients Breast Cancer Res 8 4 R34
93. J Jacquemier 2005 Typical medullary breast carcinomas have a basal/myoepithelial phenotype J Pathol 207 3 260 268
94. F Bertucci 2006 Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers Cancer Res 66 9 4636 4644
95. SM Rodriguez-Pinilla 2007 Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study Am J Surg Pathol 31 4 501 508
96. H Tsuda 2000 Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases Am J Surg Pathol 24 2 197 202
97. VL Seewaldt V Scott 2007 Images in clinical medicine. Rapid progression of basal-type breast cancer N Engl J Med 356 13 e12
98. K Collett 2005 A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors Cancer Epidemiol Biomarkers Prev 14 5 1108 1112
99. NC Turner JS Reis-Filho 2006 Basal-like breast cancer and the BRCA1 phenotype Oncogene 25 43 5846 5853
100. NC Turner 2007 BRCA1 dysfunction in sporadic basal-like breast cancer Oncogene 26 14 2126 2132
101. J Palacios 2003 Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers Clin Cancer Res 9 10 Pt 1 3606 3614
102. JB Arnes 2005 Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer Clin Cancer Res 11 11 4003 4011
103. SR Lakhani 2002 The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 9 2310 2318
104. WD Foulkes 2003 Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 95 19 1482 1485
105. N Turner A Tutt A Ashworth 2004 Hallmarks of 'BRCAness' in sporadic cancers Nat Rev Cancer 4 10 814 819
106. D Stoppa-Lyonnet 2000 Familial invasive breast cancers: worse outcome related to BRCA1 mutations J Clin Oncol 18 24 4053 4059
107. BG Haffty 2006 Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 36 5652 5657
108. L Perreard 2006 Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Res 8 2 R23
109. AR Feinstein DM Sosin CK Wells 1985 The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer N Engl J Med 312 25 1604 1608
110. L Pedersen 1995 Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer Eur J Cancer 31A 13-14 2289 2295
111. V Rapin 1988 Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma Cancer 61 12 2503 2510
112. JH Eichhorn 2004 Medullary carcinoma, provocative now as then Semin Diagn Pathol 21 1 65 73
113. V Patanaphan OM Salazar R Risco 1988 Breast cancer: metastatic patterns and their prognosis South Med J 81 9 1109 1112
114. DG Hicks 2006 Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR Am J Surg Pathol 30 9 1097 1104
115. J Gaedcke 2007 Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer Mod Pathol 20 8 864 870
116. D Palmieri 2006 Brain metastases of breast cancer Breast Dis 26 139 147
117. NL Grupka 2004 Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status Arch Pathol Lab Med 128 9 974 979
118. V Eusebi 1987 Adenomyoepithelioma of the breast with a distinctive type of apocrine adenosis Histopathology 11 3 305 315
119. MP Foschini V Eusebi 1998 Carcinomas of the breast showing myoepithelial cell differentiation. A review of the literature Virchows Arch 432 4 303 310
120. SR Lakhani 1995 Malignant myoepithelioma (myoepithelial carcinoma) of the breast: a detailed cytokeratin study J Clin Pathol 48 2 164 167
121. PS Thorner 1986 Malignant myoepithelioma of the breast. An immunohistochemical study by light and electron microscopy Cancer 57 4 745 750
122. M Pia-Foschini 2003 Salivary gland-like tumours of the breast: surgical and molecular pathology J Clin Pathol 56 7 497 506
123. Z Kinkor 2004 Matrix-producing breast carcinoma with myoepithelial differentiation-description of 11 cases and review of literature aimed at histogenesis and differential diagnosis Ceska Gynekol 69 3 229 236
124. J Stingl 2001 Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue Breast Cancer Res Treat 67 2 93 109
125. D Birnbaum 2004 Basal and luminal breast cancers: basic or luminous? (review) Int J Oncol 25 2 249 258
126. G Dontu 2003 Stem cells in normal breast development and breast cancer Cell Prolif 36 Suppl 1 59 72
127. F Behbod JM Rosen 2005 Will cancer stem cells provide new therapeutic targets? Carcinogenesis 26 4 703 711
128. Reis-Filho JS (2005) Re: Korsching et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206:451-457.
129. J Pathol (2005) 207(3):367-369; author reply 370-371
130. WD Foulkes 2004 BRCA1 functions as a breast stem cell regulator J Med Genet 41 1 1 5
131. AM Hosey 2007 Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer J Natl Cancer Inst 99 22 1683 1694
132. A McCarthy 2007 A mouse model of basal-like breast carcinoma with metaplastic elements J Pathol 211 4 389 398
133. VE Gould 1986 Histogenesis and differentiation: a re-evaluation of these concepts as criteria for the classification of tumors Hum Pathol 17 3 212 215
134. DC Brown 1987 Cytokeratin expression in smooth muscle and smooth muscle tumours Histopathology 11 5 477 486
135. PT Simpson 2005 Molecular evolution of breast cancer J Pathol 205 2 248 254